Clinical Potential of Tissue Tumor Mutational Burden (tTMB) and Blood TMB (bTMB) as a Biomarker in Non-Small Cell Lung Cancer

被引：0
|
作者：
Zhou, J. [1 ]
Zhou, J. [1 ]
Chen, X. [1 ]
Zhu, Y. [1 ]
Fang, L. [1 ]
Bao, Z. [1 ]
Liu, R. [1 ]
Cao, H. [1 ]
Sun, W. [1 ]
Zhang, T. [2 ]
Lin, J. [2 ]
Yu, B. [2 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Dept Resp Dis, Thorac Dis Ctr,Coll Med, Hangzhou, Zhejiang, Peoples R China
[2] Burning Rock Biotech, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
tTMB; bTMB; NSCLC;
D O I：
10.1016/j.jtho.2019.08.751
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.01-36
引用
收藏
页码：S370 / S370
页数：1
相关论文
共 50 条
  • [41] Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial
    Kim, Edward S.
    Velcheti, Vamsidhar
    Mekhail, Tarek
    Yun, Cindy
    Shagan, Sarah M.
    Hu, Sylvia
    Chaes, Young Kwang
    Leal, Ticiana A.
    Dowell, Jonathan E.
    Tsai, Michaela L.
    Dakhil, Christopher S. R.
    Stella, Philip
    Jin, Yanling
    Shames, David S.
    Schleifman, Erica
    Fabrizio, David A.
    Phan, See
    Socinski, Mark A.
    NATURE MEDICINE, 2022, 28 (05) : 939 - +
  • [42] Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial
    Edward S. Kim
    Vamsidhar Velcheti
    Tarek Mekhail
    Cindy Yun
    Sarah M. Shagan
    Sylvia Hu
    Young Kwang Chae
    Ticiana A. Leal
    Jonathan E. Dowell
    Michaela L. Tsai
    Christopher S. R. Dakhil
    Philip Stella
    Yanling Jin
    David S. Shames
    Erica Schleifman
    David A. Fabrizio
    See Phan
    Mark A. Socinski
    Nature Medicine, 2022, 28 : 939 - 945
  • [43] Impact of tumor mutational burden on overall survival in patients with non-small cell lung cancer treated with immunotherapy
    Awad, Mark
    Mahadevan, Navin
    Polio, Andrew
    Vokes, Natalie
    Aguilar, Elizabeth
    Ricciuti, Biagio
    Lamberti, Giuseppe
    Recondo, Gonzalo
    Leonardi, Giulia
    Adeni, Anika
    Janne, Pasi
    Van Allen, Eliezer
    Albayrak, Adem
    Umeton, Renato
    Sholl, Lynette
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [44] Tumor Mutational Burden in Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy: Outcomes in a Multiethnic Cohort
    Munoz-Arcos, L.
    D'Aiello, A.
    Herbert, J.
    Cheng, H.
    Halmos, B.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S408 - S409
  • [45] Analytic validation of tumor mutational burden as a companion diagnostic for combination immunotherapy in non-small cell lung cancer
    Fabrizio, D. A.
    Milbury, C.
    Yip, W-K.
    Ramamurthy, L.
    Bai, X.
    Pattani, V.
    Maness, P.
    Cowen, A.
    Fedorchak, K.
    Ma, P.
    Frampton, G. M.
    Connelly, C.
    Li, Y.
    ANNALS OF ONCOLOGY, 2018, 29 : 16 - 16
  • [46] Clinical potential of circulating tumor DNA (ctDNA)-based molecular response (MR) and baseline blood-based tumor mutational burden (bTMB) for monitoring response to firstline (1L) chemoimmunotherapy in advanced squamous non-small cell lung cancer (sqNSCLC)
    Ciardiello, F.
    Feng, Z.
    Smith, N. R.
    Andric, Z. G.
    Shell, S.
    Yablonovitch, A.
    Guezel, G.
    Scheuenpflug, J.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1050 - S1051
  • [47] Tumor Mutational Burden by TSO500 Next Generation Sequencing Panel and Clinical Outcome in Non-Small Cell Lung Cancer
    Cuppens, K.
    Froyen, G.
    Cruys, B.
    Geerdens, E.
    Achten, R.
    Vanbockrijck, M.
    Maes, B.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S738 - S739
  • [48] Smoking Status Is Not a Replacement Biomarker for Tumor Mutation Burden in Non-Small Lung Cancer
    Sharpnack, M.
    Cho, J. H.
    Johnson, T.
    Otterson, G.
    Shields, P.
    Huang, K.
    Carbone, D.
    He, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S444 - S445
  • [49] Blood tumor mutational burden and dynamic changes in circulating tumor DNA predict response to pembrolizumab treatment in advanced non-small cell lung cancer
    Stensgaard, Simone
    Thomsen, Astrid
    Helstrup, Sofie
    Meldgaard, Peter
    Sorensen, Boe S.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (05) : 971 - +
  • [50] Oncogene addiction and tumor mutational burden in non-small-cell lung cancer: Clinical significance and limitations
    Smolle, Elisabeth
    Leithner, Katharina
    Olschewski, Horst
    THORACIC CANCER, 2020, 11 (02) : 205 - 215
12345